Palatin Technologies Inc.

Market cap: $22,937,560

Exchange: ASE

Sector: Health Technology

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Key Statistics

Company Name

Palatin Technologies Inc.

Average Volume (10 days)

74,421

Average Volume (30 days)

204,180

Moving Average (50 days)

$1.89

Moving Average (200 days)

$2.12

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-0.8328

Market Cap

22,937,560

Shares Outstanding

11,946,646

52-Week High Split Adjust Only

5

52-Week Low Split Adjust Only

1.43

Employee Count

46

Beta

0

Next Earnings Date

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.05%

Past 30 days

0.11%

Past 3 months

-0.32%

Past 6 months

-0.13%

Past year

-0.55%

Past 2 years

-0.81%

Past 5 years

-0.91%

Max % Change

-1%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Palatin Technologies Inc.PTN-770.941.86n/a-770.94-330.89
Peer AvgN/A3.863.685.33.863.96
Johnson & JohnsonJNJ5.296.77n/a5.295.40
Astrazeneca plc - ADRAZN5.4010.33n/a5.405.85
Neurocrine Biosciences, Inc.NBIX8.707.5544.78.708.17
ANI Pharmaceuticals IncANIP2.052.15n/a2.052.79
Ardelyx IncARDXn/an/a-5.1n/an/a
Ligand Pharmaceuticals, Inc. - Class BLGND9.402.6319.19.409.49
Medicinova IncMNOVn/an/a-14.1n/an/a
GlycoMimetics IncGLYCn/an/a-2.0n/an/a